The National Institute of Health and Clinical Excellence (NICE) has given a preliminary ‘no’ to a prostate cancer drug that we helped develop, because it’s too expensive. Professor Peter Johnson, Cancer Research UK’s chief clinician, calls for a solution to be found so that the drug which offers valuable extra months to men with advanced prostate cancer, can be approved. There’s more information about this story on our blog: bit.ly
Read More...Cancer News
- Bladder Cancer (65)
- Brain Tumor Cancer (38)
- Breast Cancer (8038)
- Cancer Bulletins (543)
- Cancer Clinical Trials (5107)
- Cancer Treatment (1240)
- Colon Rectal Cancer (5960)
- General Cancer (17337)
- Leukemia Lymphoma Cancer (10605)
- Lung Mesothelioma Asbestos (4905)
- Ovarian Cervical Uterine Cancer (1176)
- Pancreatic Cancer (56)
- Prostate Cancer (6907)
- Skin Cancer (6052)
- Uncategorized (53)
-
Cancer News Topics
- Breast cancer treatment ‘very effective’
- Chemical that makes naked mole rats cancer-proof discovered
- Estrogen is a new weapon against urinary tract infection in postmenopausal women
- Drug shows surprising efficacy as treatment for chronic leukemia, mantle cell lymphoma
- Naked mole-rat gives cancer clues
- Researchers Discover Secret To Naked Moles Rats Resistance To Cancer
- How to find the right sunscreen for kids
- TrueBliss Launch Dance Challenge for Child Cancer
- ‘Chase and Run’ Mechanism Explains Cancer Metastasis
- Climb4Life to raise money Saturday in Boulder for ovarian cancer research
- Climb4Life to raise money Saturday in Boulder for ovarian cancer research
- Denver Zoo lion gets unique cancer treatment
- Denver Zoo lion gets unique cancer treatment
- Observation is safe, cost-saving in low-risk prostate cancer
- Observation is safe, cost-saving in low-risk prostate cancer
- Protein Being Studied To Fight Cancer; May Cause Toxicity In Cardiac Cells
- Protein Being Studied To Fight Cancer; May Cause Toxicity In Cardiac Cells
- Whole Exome Sequencing Seeks Out Adenoid Cystic Carcinoma
- ‘Undruggable’ To Druggable: A New Target For Cancer Drug Development
- ‘Undruggable’ To Druggable: A New Target For Cancer Drug Development
- Aspirin may fight cancer by slowing DNA damage
- Nanog protein promotes growth of head and neck cancer
- New resistance mechanism to chemotherapy in breast and ovarian cancer
- Chemical probe confirms that body makes its own rotten egg gas, H2S, to benefit health
- Reader Submitted: Terri Brodeur Breast Cancer Foundation Seeks Two Team Lead Volunteers